Caveolins: Expression of Regulating Systemic Physiological Functions in Various Predicaments

Abstract

Caveolins are membrane proteins which contains caveolae. They are present in the plasma membrane. Many researchers found that caveolae have been associated with expression of the caveolins in major physiological networks of mammalian cells. Subtypes of caveolin including caveolin-1 and caveolin-2 have been found in micro arteries of rat brain, while caveolin-3 has been found in astrocytes. Caveolin-1 and caveolae play important roles in Alzheimer’s disease, cancer, ischemic preconditioning-mediated cardio-protection, postmenopausal alterations in women, and age-related neurodegeneration. Caveolin-1 may modify fatty acid transmembrane flux in adipocytes. The discovery of a link between ischemia preconditioning, cardio-protection, and endothelial nitric oxide synthase has supported cardiovascular research tremendously. Therefore, caveolins are effective in regulation of cellular, cardiovascular, brain, and immune processes. They ascertain new signalling pathways and link the functionalities of these pathways. This review paper focuses on contribution of caveolins in various conditions, caveolin expression at the molecular level and their physiological effects in many organ systems.

Keywords

caveolin - ischemic preconditioning - nitric oxide - ovariectomy - cancer progression - immunosenescence.

Publikationsverlauf

Eingereicht: 26. Januar 2022

Angenommen: 28. Februar 2022

Artikel online veröffentlicht:
14. April 2022

• References

• 1 Srivastav RK, Ansari TM, Prasad M. et al. Caveolins; An Assailant or An Ally of Various Cellular Disorders. Drug Res (Stuttg) 2019; 69: 419-427
• 2 Takaguri A, Kamato M, Satoh Y. et al. Effect of alteration of caveolin-1 expression on doxorubicin-induced apoptosis in H9c2 cardiac cells. Cell Biol Int 2015; 39: 1053-1060
• 3 Das M, Das DK. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease. Ann Med 2012; 44: 530-541
• 4 Fridolfsson HN, Roth DM, Insel PA. et al. Regulation of intracellular signaling and function by caveolin. FASEB J 2014; 28: 3823-3831
• 5 Virgintino D, Robertson D, Errede M. et al. Expression of caveolin-1 in human brain microvessels. Neuroscience 2002; 115: 145-152
• 6 Chakrabarti S, Morton JS, Davidge ST. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol 2014; 30: 705-712
• 7 Sun J, Zhang X, Wang C. et al. Curcumin decreases hyperphosphorylation of Tau by down-regulating Caveolin-1/GSK-3β in N2a/APP695swe cells and APP/PS1 double transgenic Alzheimer’s disease Mice. Am J Chin Med 2017; 45: 1667-1682
• 8 Bender F, Montoya M, Monardes V. et al. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 2002; 35: 151-167
• 9 Vallejo J, Hardin CD. Metabolic organization in vascular smooth muscle: distribution and localization of caveolin-1 and phosphofructokinase. Am J Physiol Cell Physiol 2004; 286: C43-C54
• 10 King DL, Arendash GW. Maintained synaptophysin immuno reactivity in “Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res 2002; 926: 58-68
• 11 Li Y, Liu LB, Ma T. et al. Effect of caveolin-1 on the expression of tight junction-associated proteins in rat glioma-derived microvascular endothelial cells. Int J Clin Exp Pathol 2015; 8: 13067-13074
• 12 Conti E, Carrozza C, Capoluongo E. et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004; 110: 2260-2265
• 13 Versari D, Daghini E, Virdis A. et al. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009; 157: 527-536
• 14 Foulquier S, Dupuis F, Perrin-Sarrado C. et al. Differential effects of short-term treatment with two AT1 receptor blockers on diameter of pial arterioles in SHR. PLoS One 2012; 7: e42469
• 15 Kypreos KE, Zafirovic S, Petropoulou PI. et al. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology. J Cardiovasc Pharmacol Ther 2014; 19: 256-268
• 16 Goligorsky MS, Li H, Brodsky S. et al. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol 2002; 283: F1-F10
• 17 Prabhakar P, Cheng V, Michel T. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae. J Biol Chem 2000; 275: 19416-19421
• 18 Woodman OL, Missen MA, Boujaoude M. Diadzein and 17beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharm 2004; 44: 155-163
• 19 Batova S, DeWever J, Godfraind T. et al. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovasc Res 2006; 71: 478-485
• 20 Razani B, Engelman JA, Wang XB. et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001; 276: 38121-38138
• 21 Hehlgans S, Cordes N. Caveolin-1 an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res 2011; 1: 521-530
• 22 Roch-Arveiller M, Couderc R. Caveolae membrane domains, specialized transmembrane exchange zones implicated in cell signalling. Ann Biol Clin 2000; 58: 141-146
• 23 Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 2009; 335: 41-47
• 24 Saleh DO, El-Awdan SA, Nofel S. Estrogens improve the cardiovascular alterations in fructose-induced insulin resistant ovariectomized rats. International journal of pharmacy and pharmaceutical science 2015; 7: 241-247
• 25 Shatz M, Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. Int J Radiat Biol 2008; 84: 177-189
• 26 Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288: C494-C506
• 27 Williams TM, Hassan GS, Li J. et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005; 280: 25134-25145
• 28 Wiechen K, Sers C, Agoulnik A. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001; 158: 833-839
• 29 Witkiewicz AK. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 2010; 10: 135-143
• 30 Gu Y, Cai R, Zhang C. et al. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway. FASEB J 2019; 33: 441-444
• 31 Chen L, Xue Y, Zheng J. et al. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5. Front Mol Neurosci 2018; 11: 35
• 32 Neri M, Riezzo I, Pascale N. et al. Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists. Mediators Inflamm 2017; 2017: 7018393
• 33 Lastra G, Syed S, Kurukulasuriya LR. et al. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am 2014; 43: 103-122
• 34 Garlid KD, Costa AD, Quinlan CL. et al. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 2009; 46: 858-866
• 35 Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008; 48: 359-391
• 36 Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609
• 37 Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol 2012; 2: 120
• 38 Li R, Cui J, Shen Y. Brain Sex Matters: estrogen in cognition and Alzheimer’s disease. Mol Cell Endocrinol 2014; 389: 13-21
• 39 Marin R, Diaz M. Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause. Front Neurosci 2018; 12: 128
• 40 Head BP, Peart JN, Panneerselvam M. et al. Loss of caveolin-1 accelerates neurodegeneration and aging. PLoS One 2010; 5: e15697
• 41 Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron 2009; 63: 287-303
• 42 Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002; 110: 597-603
• 43 Leduc V, Jasmin-Bélanger S, Poirier J. APOE and cholesterol homeostasis in Alzheimer’s disease. Trends Mol Med 2010; 16: 469-477
• 44 Thompson BR, Lobo S, Bernlohr DA. Fatty acid flux in adipocytes: the in’s and out’s of fat cell lipid trafficking. Mol Cell Endocrinol 2010; 318: 24-33
• 45 Lo HP, Nixon SJ, Hall TE. et al. The caveolin-cavin system plays a conserved and critical role in mechanoprotection of skeletal muscle. J Cell Biol 2015; 210: 833-849
• 46 Nguyen KC, Cho KA. Versatile Functions of Caveolin-1 in Aging-related Diseases. Chonnam Med J 2017; 53: 28-36
• 47 Medina FA, de Almeida CJ, Dew E. et al. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella entericaserovar Typhimurium infection. Infect Immun 2006; 74: 6665-6674
• 48 Lim JS, Nguyen KC, Han JM. et al. Direct Regulation of TLR5 Expression by Caveolin-1. Mol Cells 2015; 38: 1111-1117